Ovarian reserve markers in women with polyendocrine metabolic ovarian syndrome and subclinical hypothyroidism: the modifying role of thyroid autoimmunity
Year: 2026
Type: article
Study design: Observational Study
Abstract: To assess the relationship between subclinical hypothyroidism (SCH), thyroid autoimmunity (TAI), and ovarian reserve parameters in women newly diagnosed with polyendocrine metabolic ovarian syndrome (PMOS), and to evaluate whether TAI modifies this relationship. This retrospective cross-sectional study included irregularly menstruating women with PMOS and no overt thyroid dysfunction. Participants were stratified by thyroid-stimulating hormone (TSH) concentrations as SCH0 (0.27–2.49 mIU/L), SCH1 (2.50–4.20 mIU/L), and SCH2 (> 4.20 mIU/L), and by TAI status. Group comparisons, correlation analyses, and multivariable linear and logistic regression models were performed. Among 897 women with PMOS, no significant differences in Anti-Müllerian hormone (AMH) ( p = 0.362), follicle-stimulating hormone ( p = 0.566), luteinizing hormone ( p = 0.528), estradiol ( p = 0.833), polycystic ovarian morphology ( p = 0.793), or cycle-related ovarian structures ( p = 0.066) were found across TSH categories. In phenotype D, AMH varied by TSH category ( p = 0.017). After multivariable adjustment, thyroid-related variables showed no independent associations with ovarian reserve markers or related parameters (all p > 0.05). In women newly diagnosed with PMOS, thyroid-related variables were not independently associated with ovarian reserve markers, with variability primarily explained by body mass index, age, and PMOS phenotype.
Source: Journal of Ovarian Research
Authors: Rafal Baran, Robert Jach, Iwona Gawron
Institutions: Szpital Uniwersytecki w Krakowie, Jagiellonian University
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,290
OpenAlex ID: W7234415143
